Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 4982-4992, September 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Segal-Bendirdjian, E.
Right arrow Articles by Le Pecq, J.-B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Segal-Bendirdjian, E.
Right arrow Articles by Le Pecq, J.-B.

Selective Loss of Mitochondrial DNA after Treatment of Cells with Ditercalinium (NSC 335153), an Antitumor Bis-intercalating Agent

Evelyne Segal-Bendirdjian1, Dominique Coulaud, Bernard P. Roques and Jean-Bernard Le Pecq

Unité de Physicochimie Macromoléculaire (CNRS UA 147, INSERM U 140) [E. S-B., J-B. L.] and Laboratoire de Microscopie Cellulaire et Moléculaire [D. C.], Institut Gustave Roussy, 94805 Villejuif Cédex; and Département de Chimie Organique (CNRS UA 498, INSERM U 266), UER des Sciences Pharmaceutiques et Biologiques, 4, Avenue de l'Observatoire, 75006 Paris; France

Ditercalinium (NSC 335153), a bifunctional intercalating molecule with antitumor activity, is found to express its toxicity through a mechanism of action completely different from that of other monointercalating agents.

Electron microscopic observation of ditercalinium-treated cells shows a drastic alteration of mitochondrial structure. Cells deficient in mitochondrial respiration (GSK3 cells) isolated by A. Franchi et al. (Int. J. Cancer, 27: 819–827, 1981) are about 25-fold more resistant than cells deficient in glycolysis (DS7 cells) isolated by J. Pouysségur et al. (Proc. Natl. Acad. Sci. USA, 77: 2698–2701, 1980). Revertants have been isolated from GSK3 cells. In these cells, the sensitivity to ditercalinium has been recovered with mitochondrial respiration. Ditercalinium treatment of L1210 leukemic mouse cells leads to a specific elimination of mitochondrial DNA detected by DNA-DNA hybridization. No measurable alteration of nuclear DNA is observed. In contrast, the monomeric analogue of ditercalinium only alters nuclear DNA and does not change the mitochondrial DNA content. The activity of cytochrome c oxidase, an enzyme which contains a subunit coded by the mitochondrial DNA, decreases exponentially in treated cells with a half-life of 24 h, corresponding to the turnover of the enzyme.

These results suggest that ditercalinium exerts a specific cytotoxic effect at the level of mitochondrial DNA. This action could account for the delayed cytotoxicity induced by this compound.

1 To whom requests for reprints should be addressed, at the Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cédex, France

Received 1/11/88. Revised 5/24/88. Accepted 6/ 2/88.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Inoue, S. Ito, D. Takai, A. Soejima, H. Shisa, J.-B. LePecq, E. Segal-Bendirdjian, Y. Kagawa, and J.-I. Hayashi
Isolation of Mitochondrial DNA-less Mouse Cell Lines and Their Application for Trapping Mouse Synaptosomal Mitochondrial DNA with Deletion Mutations
J. Biol. Chem., June 13, 1997; 272(24): 15510 - 15515.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.